Literature DB >> 32419890

Amyloid nodule and primary pulmonary lymphoma in the same lung: Radiologic-pathologic correlation of a rare combination.

Andrei Jipa1, Jonathan Glaab2.   

Abstract

A 61-year-old man presented for lung cancer screening with low dose CT. A spiculated right apical nodule suspicious for primary lung malignancy and an indeterminate small basilar consolidation were identified. PET/CT was notable for increased FDG uptake in the basilar consolidation. Transthoracic needle biopsy of both lesions was performed which lead to pathologic diagnoses of pulmonary amyloid nodule for the apical nodule and pulmonary extramarginal zone lymphoma of the mucosa associate lymphoid tissue for the basilar consolidation. While incidental findings are common in lung cancer screening CT, exceedingly rare diagnoses or combinations or diagnoses may also be encountered. This case also underscores the value of pathologic diagnosis in cases of indeterminate lung nodules.
© 2020 The Authors. Published by Elsevier Inc. on behalf of University of Washington.

Entities:  

Keywords:  Amyloid lung nodule; Lung cancer screening; Pulmonary lymphoma; Pulmonary nodule

Year:  2020        PMID: 32419890      PMCID: PMC7214772          DOI: 10.1016/j.radcr.2020.04.016

Source DB:  PubMed          Journal:  Radiol Case Rep        ISSN: 1930-0433


Introduction

Low dose CT is a widely accepted method of screening for lung cancer in high risk patients. While incidental findings commonly occur in this setting, the large number of patients screened also increases the probability of rare diagnoses and rare combinations of diagnoses. In this case a combination of a rare benign diagnosis and an uncommon incidental malignant diagnosis were made in the same patient.

Case report

A 61 year old asymptomatic male smoker presented for low dose lung CT lung cancer screening at the referral of his primary care physician. The initial study identified a suspicious 1.6 cm spiculated apical right upper lobe nodule and a small right lower lobe consolidation felt to represent infection and inflammation. A Lung-RADS category 4X was assigned due to the high risk apical nodule. PET/CT and pulmonary consultation were recommended in the original report. The patient was referred to pulmonary medicine who recommended CT chest with contrast and whole body PET/CT. The apical nodule and a 1-2 cm right lower lobe consolidation (Figs. 1 and 2) were again noted on CT. PET/CT demonstrated increased FDG uptake in the basilar consolidation (Fig. 3A) but not in the apical nodule (Fig. 3B). There was no other significant abnormality on whole body PET/CT. Given the high risk location, history and morphologic features the nodule was deemed radiographically indeterminate and further consultation with thoracic surgery was initiated. At this point the basilar consolidation also displayed an indeterminate combination of radiologic and metabolic characteristics consistent with infectious, inflammatory, or neoplastic etiology.
Fig. 1

Contrast enhanced CT chest demonstrates spiculated nodule in the peripheral right upper lobe. CT characteristics are suspicious for primary lung malignancy.

Fig. 2

Contrast enhanced CT chest again demonstrates the right upper lobe nodule as well as a right lower lobe consolidation abutting the major fissure. Serendipitously, both abnormalities were visible on the same sagittal slice.

Fig. 3

A (right) FDG PET/CT demonstrates increased FDG uptake in the right lower lobe consolidation. This radiographic and metabolic appearance is nonspecific to infectious, inflammatory, or neoplastic lesions. Image 3B (left) FDG PET/CT does not demonstrate increased FDG uptake in the right upper lobe nodule.

Contrast enhanced CT chest demonstrates spiculated nodule in the peripheral right upper lobe. CT characteristics are suspicious for primary lung malignancy. Contrast enhanced CT chest again demonstrates the right upper lobe nodule as well as a right lower lobe consolidation abutting the major fissure. Serendipitously, both abnormalities were visible on the same sagittal slice. A (right) FDG PET/CT demonstrates increased FDG uptake in the right lower lobe consolidation. This radiographic and metabolic appearance is nonspecific to infectious, inflammatory, or neoplastic lesions. Image 3B (left) FDG PET/CT does not demonstrate increased FDG uptake in the right upper lobe nodule. Thoracic surgical consultant recommended tissue sampling of both the nodule and the consolidation. CT guided core needle biopsy was successfully performed by the hospital's radiology department for both lesions (Fig 4A and B). While the procedure was complicated by pneumothorax, the patient was immediately decompressed with a pleural catheter and had a rapid recovery, being discharged the next day.
Fig. 4

A (top) Noncontrast CT performed during biopsy demonstrates needle tip in the right lower lobe consolidation and developing pneumothorax. Image 4B (bottom) noncontrast CT performed during biopsy demonstrates needle tip in the right upper lobe nodule.

A (top) Noncontrast CT performed during biopsy demonstrates needle tip in the right lower lobe consolidation and developing pneumothorax. Image 4B (bottom) noncontrast CT performed during biopsy demonstrates needle tip in the right upper lobe nodule. Biopsy yielded unexpected results for both nodules. The apical nodule contained amyloid with moderately cellular lymphoplasmacytic infiltrate. Amyloid was confirmed as congophilic material demonstrating classic apple-green birefringence on polarized microscopy (Fig. 5). A pathologic diagnosis of benign amyloid nodule or amyloidoma was made.
Fig. 5

Congo Red Stain, polarized microscopy under 20x magnification demonstrates congophilic material with apple-green birefringence consistent with amyloid.

Congo Red Stain, polarized microscopy under 20x magnification demonstrates congophilic material with apple-green birefringence consistent with amyloid. The basilar nodule contained dense lymphoid tissue with characteristics of lymphoma (Fig. 6). Immunostaining was positive for CD20, BCL-2 but negative for CD5, CD10 and CD42 suggesting an extranodal marginal zone lymphoma, also known as a lymphoma of the mucosa-associated lymphoid tissue (MALT) (Fig. 7A-D). The patient was referred to medical and radiation oncology. Given the lack of other suspicious areas on PET/CT, this was determined to be local disease and the patient was offered definitive treatment with radiotherapy alone.
Fig. 6

Standard H&E stain under 40x magnification demonstrates dense lymphocytic infiltrate.

Fig. 7

Figure 7A (top left) and figure 7B (top right). Immunostaining demonstrates significantly more cells positive for kappa light chain (7A) than lambda light chain (7B) suggesting a clonal lymphocyte population consistent with lymphoma. Figure 7C (bottom left). The cells stain positive for CD20, indicating B cell lineage Figure 7D (bottom right). The cells stain positive for BCL-2, consistent with marginal zone lymphoma.

Standard H&E stain under 40x magnification demonstrates dense lymphocytic infiltrate. Figure 7A (top left) and figure 7B (top right). Immunostaining demonstrates significantly more cells positive for kappa light chain (7A) than lambda light chain (7B) suggesting a clonal lymphocyte population consistent with lymphoma. Figure 7C (bottom left). The cells stain positive for CD20, indicating B cell lineage Figure 7D (bottom right). The cells stain positive for BCL-2, consistent with marginal zone lymphoma. The patient underwent radiotherapy with a total dose to 36 Gray delivered in 10 fractions. Radiotherapy was well tolerated and follow up CT 8 weeks post treatment demonstrated significant decrease in size of the basilar consolidation (Fig. 8A and B).
Fig. 8

A (Right) Initial contrast-enhanced CT demonstrates pulmonary MALT lymphoma presenting as right lower lobe consolidation. Figure 8B (Left). Follow up study performed 4 weeks after completion of radiotherapy demonstrates significantly decreased size of the right lower lobe consolidation consistent with treatment response.

A (Right) Initial contrast-enhanced CT demonstrates pulmonary MALT lymphoma presenting as right lower lobe consolidation. Figure 8B (Left). Follow up study performed 4 weeks after completion of radiotherapy demonstrates significantly decreased size of the right lower lobe consolidation consistent with treatment response.

Discussion

Amyloid nodules are rare benign lung lesions representing a focal deposit of amyloid material; they have been alternatively been called amyloidomas or focal amyloidosis. Importantly, amyloid nodules are not associated with and are distinct from the pulmonary manifestations of systemic forms of amyloidosis. These are rare lesions of uncertain prevalence, without clear risk factors or associations although most have been reported in adults [1]. The highest prevalence has been reported in the sixth decade of life [1]; however this may be biased due to increased imaging of older adults. Typically, amyloid nodules present as solitary solid lung nodules, often with chest radiographic and CT characteristics indistinguishable from nonmetastatic primary lung tumors [1,2]. In this case, an amyloid nodule presented with a suspicious spiculated morphology. Due to the inability to distinguish amyloid nodules from primary lung cancers, they have traditionally been diagnosed by surgical pathology following lung resection [3]. While amyloid nodules have been incidentally detected using amyloid-specific nuclear medicine tracers [4], their FDG-PET characteristics have yet to be systematically described. The lack of increased metabolism observed in this case, however is consistent with the pathophysiologic process of amyloid deposition. Given their rarity and similar CT features to primary lung cancer, diagnosis of amyloid nodule is exceeding difficult without biopsy and this diagnostic consideration should not change standard management of high-risk lung nodules. While radiologic diagnosis is difficult; the pathologic findings are both classic and distinctive; once a pathologic diagnosis can be reached the patient can be safely spared surgical treatment or radiotherapy. Compared to amyloid nodule, pulmonary MALT lymphoma is a more common entity. The most common primary lung lymphoma, these are indolent malignancies that tend that demonstrate slow lymphangitic and peribronchial spread. In late stages distant metastases are possible. They are primarily tumors of adulthood with a maximum incidence during the sixth decade of life [5], [6], [7]. Pathogenesis may involve a bacterial infectious agent, specifically Chlamydia psitacci or Achromobacter xylosoxidans and active research is being undertaken in this direction [7]. There is an increased risk of development in patients with autoimmune disease (especially Sjogren syndrome), HIV, systemic amyloidosis, or lymphoid interstitial pneumonia [5,6]. Tumors either tend to be diagnosed in 2 clinical scenarios: cough or dyspnea associated with extensive lymphomatous involvement of the lung or an incidental finding of CT performed for other reasons [5], [6], [7]. Pulmonary MALT lymphomas have a protean appearance on CT. The most common presenting abnormality reported is pulmonary consolidation, although the disease can also present as pulmonary nodules or ground glass opacities. Air bronchograms may be present in larger consolidations [5,6,8,9]. Disease can be unifocal or multifocal, unilateral or bilateral on presentation [6,9]. A retrospective study of 53 cases reported 44% as presenting with consolidations with 66% with bilateral lesions [8], although a smaller retrospective series of 24 cases [9] reported consolidations in most cases and bilateral abnormalities in most cases on presentation. Pulmonary MALT lymphomas, like most lymphomas, demonstrate increased FDG uptake [5,6]. In our case, the patient presented with a single FDG avid pulmonary consolidation. Given their varied radiologic appearance, pulmonary MALT lymphoma may be considered a differential diagnosis for many different imaging patterns on lung CT, but should be especially suspected in cases of persistent pulmonary consolidations. Consolidations detected during screening such as this case are technically not nodules and therefore not triaged using Lung-RADS. PET/CT is a valuable tool in diagnosis. A lack of FDG avidity would make lymphoma very unlikely but increased FDG uptake is seen in both benign and malignant processes. The prognosis for pulmonary MALT lymphomas, and indeed for MALT lymphomas in general is excellent. Treatment with radiotherapy alone for local disease or radiotherapy with rituximab for advanced disease is effective. There is a risk of late transformation to histologically and clinically aggressive forms of lymphoma; unfortunately this risk is unpredictable.

Conclusion

While incidental findings are a common occurrence with lung cancer screening CT, the combination of a rare benign lesion and an uncommon lymphoma is exceedingly rare and has not been reported before. The case underscores the value of biopsy where imaging findings are indeterminate and the value of radiology-pathologic correlation.
  9 in total

1.  Solitary amyloid nodule in the lung.

Authors:  I Yoshino; Y Katsuda; H Yokoyama; T Yano; Y Ichinose
Journal:  Scand Cardiovasc J       Date:  1997       Impact factor: 1.589

2.  Pulmonary MALT lymphoma: imaging findings in 24 cases.

Authors:  L J King; S P Padley; A C Wotherspoon; A G Nicholson
Journal:  Eur Radiol       Date:  2000       Impact factor: 5.315

3.  A solitary amyloid nodule in the lung.

Authors:  M R Chaudhuri; D J Parker
Journal:  Thorax       Date:  1970-05       Impact factor: 9.139

Review 4.  Unusual primary lung tumors: a radiologic-pathologic overview.

Authors:  Ana Giménez; Tomás Franquet; Rosa Prats; Pilar Estrada; Jordi Villalba; Silvia Bagué
Journal:  Radiographics       Date:  2002 May-Jun       Impact factor: 5.333

5.  Lung amyloid nodule detected by 99mTc-aprotinin scintigraphy.

Authors:  Satoru Ishii; Kazuo Kubota; Ryogo Minamimoto; Rikiya Kouketu; Miyako Morooka; Shigeo Kawai; Yuichiro Takeda; Nobuyuki Kobayashi; Haruhito Sugiyama
Journal:  Ann Nucl Med       Date:  2012-05-19       Impact factor: 2.668

Review 6.  The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance.

Authors:  Emanuele Zucca; Francesco Bertoni
Journal:  Blood       Date:  2016-03-17       Impact factor: 22.113

7.  Mucosa-associated lymphoid tissue lymphoma: multimodality imaging and histopathologic correlation.

Authors:  Daichi Hayashi; Brooke Devenney-Cakir; John C Lee; Se-Hyung Kim; June Cheng; Sarah Goldfeder; Byung-Ihn Choi; Ali Guermazi
Journal:  AJR Am J Roentgenol       Date:  2010-08       Impact factor: 3.959

Review 8.  Primary Pulmonary Lymphoid Lesions: Radiologic and Pathologic Findings.

Authors:  Arlene Sirajuddin; Kirtee Raparia; Vanessa A Lewis; Teri J Franks; Sabeen Dhand; Jeffrey R Galvin; Charles S White
Journal:  Radiographics       Date:  2016 Jan-Feb       Impact factor: 5.333

9.  Pulmonary MALT Lymphoma has variable features on CT.

Authors:  Wen Deng; Ying Wan; Jian-Qun Yu
Journal:  Sci Rep       Date:  2019-06-17       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.